OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 26 citing articles:

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 465

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics
Ying Feng, Zhibo Yang, Jianpeng Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19

Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28

Systematic Review of Roles of Arecoline and Arecoline N-Oxide in Oral Cancer and Strategies to Block Carcinogenesis
Albert Min‐Shan Ko, Hung‐Pin Tu, Ying‐Chin Ko
Cells (2023) Vol. 12, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 28

Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer
Hongzhuang Wen, Changbao Qu, Zhu Wang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 9
Open Access | Times Cited: 28

Role of cuproptosis in understanding diseases
Shihan Cao, Qian Wang, Zhenzhen Sun, et al.
Human Cell (2023) Vol. 36, Iss. 4, pp. 1244-1252
Open Access | Times Cited: 26

A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression
Nur Fatinazwa Mohd Faizal, Saptarsi Shai, Bansi Savaliya, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 134-134
Open Access

Epithelium-derived exosomal dipeptidyl peptidase-4 involved in arecoline-induced oral submucous fibrosis
Tzong‐Ming Shieh, Nan-Chin Lin, Yen‐Wen Shen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167683-167683
Open Access

Assessing the carcinogenic potential and molecular mechanisms of arecoline in human lungs: from in silico methods to in vitro validation
Wenwen Wang
Ecotoxicology and Environmental Safety (2025) Vol. 294, pp. 118108-118108
Closed Access

PLAU serves as a prognostic biomarker correlated with perineural invasion in HNSCC
Haimeng Yin, Zixiang Zhang, Qing Zhang, et al.
Cancer Genetics (2025)
Closed Access

Review of the toxic effects and health functions of arecoline on multiple organ systems
Huiling Liu, Hao Zheng, Jiachao Zhang, et al.
Food Innovation and Advances (2024) Vol. 3, Iss. 1, pp. 31-41
Open Access | Times Cited: 3

Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway
Lei Ma, Ke Huang, Haibo Zhang, et al.
Journal of Cancer (2023) Vol. 15, Iss. 3, pp. 659-670
Open Access | Times Cited: 6

Cuproptosis-Related Biomarkers and Characterization of Immune Infiltration in Sepsis
Yuanfeng Wang, Xu Qiu, Jiao Liu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2459-2478
Open Access | Times Cited: 2

The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies
Yujie Xi, Ling Gao, S.-M. Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4

CEBPB dampens the cuproptosis sensitivity of colorectal cancer cells by facilitating the PI3K/AKT/mTOR signaling pathway
Tianchen Huang, Yong Zhang, Yachao Wu, et al.
Saudi Journal of Gastroenterology (2024)
Open Access | Times Cited: 1

Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review
Ruchi Saxena, Catherine F. Welsh, You‐Wen He
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy
Cong Xu, Shaodi Wen, Xiaoyue Du, et al.
Pharmacological Research (2024), pp. 107553-107553
Open Access | Times Cited: 1

Construction of a cuproptosis-associated long non-coding RNA risk prediction model for pancreatic adenocarcinoma based on the TCGA database
Wenguang Cui, Yaling Wang, Jianhong Guo, et al.
Medicine (2023) Vol. 102, Iss. 5, pp. e32808-e32808
Open Access | Times Cited: 3

A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
Fan Yang, Shitao Jiang, Y. Liu, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11768-e11768
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top